. 2016 Jul; 12(11):2805-2812.
doi: 10.1080/21645515.2016.1206677.

CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany

Lena M Kranz 1 Matthias Birtel 1 Lina Hilscher 1 Christian Grunwitz 1 Jutta Petschenka 1 Fulvia Vascotto 1 Mathias Vormehr 1 Ralf-Holger Voss 1 Sebastian Kreiter 1 Mustafa Diken 1 
  • PMID: 27435168
  •     59 References

No abstract available

Keywords: CIMT; antibodies; cancer immunotherapy; cellular therapy; checkpoint blockade; combination therapy; personalized therapy; tumor microenvironment; tumor vaccination.

Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory.
Giacomo Oliveira, Eliana Ruggiero, +21 authors, Chiara Bonini.
Sci Transl Med, 2015 Dec 15; 7(317). PMID: 26659572
Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity.
Koen Wagner, Mark J Kwakkenbos, +10 authors, Hergen Spits.
Proc Natl Acad Sci U S A, 2014 Nov 12; 111(47). PMID: 25385586    Free PMC article.
Adoptive transfer of anti-idiotypic T cells cure mice of disseminated B cell lymphoma.
Anne C Armstrong, Said Dermime, +3 authors, Robert E Hawkins.
J Immunother, 2004 Apr 13; 27(3). PMID: 15076140
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
Jérémy Goc, Claire Germain, +15 authors, Marie-Caroline Dieu-Nosjean.
Cancer Res, 2013 Dec 25; 74(3). PMID: 24366885
Highly Cited.
Structure-based programming of lymph-node targeting in molecular vaccines.
Haipeng Liu, Kelly D Moynihan, +6 authors, Darrell J Irvine.
Nature, 2014 Feb 18; 507(7493). PMID: 24531764    Free PMC article.
Highly Cited.
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan.
Richard Metz, Sonja Rust, +5 authors, George C Prendergast.
Oncoimmunology, 2012 Dec 25; 1(9). PMID: 23264892    Free PMC article.
Highly Cited.
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.
Rony Dahan, Emanuela Sega, +3 authors, Jeffrey V Ravetch.
Cancer Cell, 2015 Sep 17; 28(3). PMID: 26373277
Highly Cited.
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.
Eric Tran, Simon Turcotte, +10 authors, Steven A Rosenberg.
Science, 2014 May 09; 344(6184). PMID: 24812403    Free PMC article.
Highly Cited.
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement.
Rony Dahan, Bryan C Barnhart, +3 authors, Jeffrey V Ravetch.
Cancer Cell, 2016 Jun 07; 29(6). PMID: 27265505    Free PMC article.
Highly Cited.
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
Alexander J Muller, James B DuHadaway, +2 authors, George C Prendergast.
Nat Med, 2005 Feb 16; 11(3). PMID: 15711557
Highly Cited.
Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming.
Mark J Kwakkenbos, Sean A Diehl, +11 authors, Tim Beaumont.
Nat Med, 2009 Dec 22; 16(1). PMID: 20023635    Free PMC article.
Highly Cited.
Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma.
V Baldan, R Griffiths, R E Hawkins, D E Gilham.
Br J Cancer, 2015 Apr 14; 112(9). PMID: 25867267    Free PMC article.
Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.
Alexander J Muller, James B DuHadaway, +7 authors, George C Prendergast.
Cancer Immunol Immunother, 2010 Jul 20; 59(11). PMID: 20640572    Free PMC article.
New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation.
Cláudia C Oliveira, Bianca Querido, +7 authors, Thorbald van Hall.
J Immunol, 2013 Sep 21; 191(8). PMID: 24048903
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.
Gavin M Bendle, Carsten Linnemann, +11 authors, Ton N M Schumacher.
Nat Med, 2010 Apr 20; 16(5). PMID: 20400962
Highly Cited.
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
Marie-Caroline Dieu-Nosjean, Nicolas A Giraldo, +3 authors, Catherine Sautès-Fridman.
Immunol Rev, 2016 Apr 19; 271(1). PMID: 27088920
Highly Cited. Review.
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine.
Michael G E O'Rourke, Maree Johnson, +10 authors, Christopher W Schmidt.
Cancer Immunol Immunother, 2003 Apr 19; 52(6). PMID: 12682787
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
Rikke B Holmgaard, Dmitriy Zamarin, +2 authors, James P Allison.
J Exp Med, 2013 Jun 12; 210(7). PMID: 23752227    Free PMC article.
Highly Cited.
Complement is activated by IgG hexamers assembled at the cell surface.
Christoph A Diebolder, Frank J Beurskens, +16 authors, Paul W H I Parren.
Science, 2014 Mar 15; 343(6176). PMID: 24626930    Free PMC article.
Highly Cited.
Comprehensive molecular characterization of human colon and rectal cancer.
Cancer Genome Atlas Network.
Nature, 2012 Jul 20; 487(7407). PMID: 22810696    Free PMC article.
Highly Cited.
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.
Riccardo Danielli, Roberto Patuzzo, +12 authors, Mario Santinami.
Cancer Immunol Immunother, 2015 May 15; 64(8). PMID: 25971540
Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.
Qiong J Wang, Ken-Ichi Hanada, +2 authors, James C Yang.
Cancer Res, 2012 Oct 17; 72(23). PMID: 23071066    Free PMC article.
Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody.
Ann L White, H T Claude Chan, +10 authors, Martin J Glennie.
J Immunol, 2011 Jul 12; 187(4). PMID: 21742972
Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
Benjamin Weide, Thomas K Eigentler, +10 authors, Claus Garbe.
Cancer Immunol Res, 2014 Jun 08; 2(7). PMID: 24906352
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
Nicholas McGranahan, Andrew J S Furness, +33 authors, Charles Swanton.
Science, 2016 Mar 05; 351(6280). PMID: 26940869    Free PMC article.
Highly Cited.
Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial.
Julio Sotelo, Eduardo Briceño, Miguel Angel López-González.
Ann Intern Med, 2006 Mar 08; 144(5). PMID: 16520474
Highly Cited.
Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients.
Bernhard Mlecnik, Gabriela Bindea, +15 authors, Jérôme Galon.
Sci Transl Med, 2014 Mar 22; 6(228). PMID: 24648340
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
Thorbald van Hall, Elisabeth Z Wolpert, +19 authors, Rienk Offringa.
Nat Med, 2006 Mar 22; 12(4). PMID: 16550190
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Steven J Cohen, R Katherine Alpaugh, +6 authors, Jonathan D Cheng.
Pancreas, 2008 Jul 31; 37(2). PMID: 18665076
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
Claire Germain, Sacha Gnjatic, +16 authors, Marie-Caroline Dieu-Nosjean.
Am J Respir Crit Care Med, 2014 Feb 04; 189(7). PMID: 24484236
Highly Cited.
The immunocytokine L19-IL2 eradicates cancer when used in combination with CTLA-4 blockade or with L19-TNF.
Kathrin Schwager, Teresa Hemmerle, David Aebischer, Dario Neri.
J Invest Dermatol, 2012 Oct 26; 133(3). PMID: 23096716
Exome Sequencing to Predict Neoantigens in Melanoma.
Antonia L Pritchard, Julie G Burel, +6 authors, Christopher W Schmidt.
Cancer Immunol Res, 2015 Jun 07; 3(9). PMID: 26048577
Phenotypic Complexity of the Human Regulatory T Cell Compartment Revealed by Mass Cytometry.
Gavin M Mason, Katie Lowe, +6 authors, Timothy I M Tree.
J Immunol, 2015 Aug 01; 195(5). PMID: 26223658
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Jérôme Galon, Anne Costes, +13 authors, Franck Pagès.
Science, 2006 Sep 30; 313(5795). PMID: 17008531
Highly Cited.
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer.
Nicolas A Giraldo, Etienne Becht, +17 authors, Catherine Sautès-Fridman.
Clin Cancer Res, 2015 Feb 18; 21(13). PMID: 25688160
Highly Cited.
The consensus molecular subtypes of colorectal cancer.
Justin Guinney, Rodrigo Dienstmann, +37 authors, Sabine Tejpar.
Nat Med, 2015 Oct 13; 21(11). PMID: 26457759    Free PMC article.
Highly Cited.
Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies.
Fubin Li, Jeffrey V Ravetch.
Science, 2011 Aug 20; 333(6045). PMID: 21852502    Free PMC article.
Highly Cited.
Clinical implications of fibroblast activation protein in patients with colon cancer.
Leonard R Henry, Hyung-Ok Lee, +5 authors, Jonathan D Cheng.
Clin Cancer Res, 2007 Mar 17; 13(6). PMID: 17363526
Highly Cited.
Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.
Sine Reker Hadrup, Arnold H Bakker, +9 authors, Ton N Schumacher.
Nat Methods, 2009 Jun 23; 6(7). PMID: 19543285
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.
Marij J Welters, Tetje C van der Sluis, +13 authors, Sjoerd H van der Burg.
Sci Transl Med, 2016 Apr 15; 8(334). PMID: 27075626
Highly Cited.
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.
Benoit Beuselinck, Sylvie Job, +16 authors, Jessica Zucman-Rossi.
Clin Cancer Res, 2015 Jan 15; 21(6). PMID: 25583177
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.
Gabriela Bindea, Bernhard Mlecnik, +14 authors, Jérôme Galon.
Immunity, 2013 Oct 22; 39(4). PMID: 24138885
Highly Cited.
A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface.
Rob N de Jong, Frank J Beurskens, +10 authors, Paul W H I Parren.
PLoS Biol, 2016 Jan 07; 14(1). PMID: 26736041    Free PMC article.
Highly Cited.
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.
Elena Provasi, Pietro Genovese, +18 authors, Chiara Bonini.
Nat Med, 2012 Apr 03; 18(5). PMID: 22466705    Free PMC article.
Highly Cited.
Subcutaneous drug delivery and the role of the lymphatics.
Danielle N McLennan, Christopher J H Porter, Susan A Charman.
Drug Discov Today Technol, 2005 Apr 01; 2(1). PMID: 24981760
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.
Richard Metz, Courtney Smith, +10 authors, George C Prendergast.
Int Immunol, 2014 Jan 10; 26(7). PMID: 24402311    Free PMC article.
Highly Cited.
Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies.
Ann L White, H T Claude Chan, +15 authors, Martin J Glennie.
Cancer Cell, 2014 Dec 17; 27(1). PMID: 25500122    Free PMC article.
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
Elien M Doorduijn, Marjolein Sluijter, +5 authors, Thorbald van Hall.
J Clin Invest, 2016 Jan 20; 126(2). PMID: 26784543    Free PMC article.
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
Alexander J Muller, Madhav D Sharma, +9 authors, Andrew L Mellor.
Proc Natl Acad Sci U S A, 2008 Oct 28; 105(44). PMID: 18952840    Free PMC article.
Highly Cited.
Tertiary lymphoid structures in cancer and beyond.
Marie-Caroline Dieu-Nosjean, Jérémy Goc, +2 authors, Wolf Herman Fridman.
Trends Immunol, 2014 Dec 03; 35(11). PMID: 25443495
Highly Cited. Review.
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.
Etienne Becht, Aurélien de Reyniès, +7 authors, Wolf Herman Fridman.
Clin Cancer Res, 2016 Mar 20; 22(16). PMID: 26994146
Highly Cited.
IDO is a nodal pathogenic driver of lung cancer and metastasis development.
Courtney Smith, Mee Young Chang, +12 authors, Alexander J Muller.
Cancer Discov, 2012 Jul 24; 2(8). PMID: 22822050    Free PMC article.
Highly Cited.
NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
Martin A Grundy, Tong Zhang, Charles L Sentman.
Cancer Immunol Immunother, 2006 Dec 13; 56(8). PMID: 17160409
Higher throughput methods of identifying T cell epitopes for studying outcomes of altered antigen processing and presentation.
Evan W Newell.
Front Immunol, 2013 Dec 25; 4. PMID: 24367368    Free PMC article.
Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia.
W H Fridman, F M Kourilsky.
Nature, 1969 Oct 18; 224(5216). PMID: 5259376
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.
Liang-Chuan S Wang, Albert Lo, +11 authors, Steven M Albelda.
Cancer Immunol Res, 2014 Apr 30; 2(2). PMID: 24778279    Free PMC article.
Highly Cited.
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution.
Line Pedersen, Manja Idorn, +12 authors, Pernille Hojman.
Cell Metab, 2016 Feb 21; 23(3). PMID: 26895752
Highly Cited.
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.
Marios Giannakis, Xinmeng Jasmine Mu, +27 authors, Levi A Garraway.
Cell Rep, 2016 May 07; 15(4). PMID: 27149842    Free PMC article.
Highly Cited.